Tick Borne Encephalitis Market Overview
Tick Borne Encephalitis Market Size was estimated at 8.78 (USD Billion) in 2022. The Tick Borne Encephalitis Market Industry is expected to grow from 9.42(USD Billion) in 2023 to 17.8 (USD Billion) by 2032. The Tick Borne Encephalitis Market CAGR (growth rate) is expected to be around 7.33% during the forecast period (2024 - 2032).
Key Tick Borne Encephalitis Market Trends Highlighted
The tick-borne encephalitis market is witnessing a surge in demand due to the rising prevalence of tick-borne diseases and the increasing awareness about the severity of these diseases. The development of innovative vaccines and advancements in diagnostic techniques are shaping the market landscape. Additionally, growing concerns over traveler safety and the expansion of outdoor activities are influencing market growth.
Key market drivers include the expansion of vaccination programs, the growing number of travelers venturing into endemic regions, and the rising incidence of tick-borne diseases. Opportunities for market growth lie in the development of more effective vaccines, improved diagnostic tests, and the exploration of new treatment options. Recent trends in the tick-borne encephalitis market include the increasing use of combination vaccines, the development of mRNA vaccines, and the adoption of digital technologies to enhance surveillance and prevention efforts. These factors collectively contribute to the dynamic growth of the tick-borne encephalitis market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Tick Borne Encephalitis Market Drivers
Increased Awareness and Vaccination Efforts
Tick-borne encephalitis (TBE) is a viral infection that can cause inflammation of the brain and spinal cord. It is spread through the bite of an infected tick. TBE is a serious disease that can lead to permanent disability or even death. However, it can be prevented by vaccination. In recent years, there has been a growing awareness of TBE and the importance of vaccination. This has led to an increase in vaccination rates, which has helped to reduce the incidence of TBE.
The Tick Borne Encephalitis Market Industry is expected to witness growth due to growing awareness of the disease and increasing vaccination efforts undertaken by governments and healthcare organizations. Additionally, the rising incidence of tick-borne diseases is anticipated to drive the growth of the TBE market. Furthermore, the introduction of new vaccines and advancements in diagnostic techniques are expected to contribute to the market's growth. The increasing healthcare expenditure and government initiatives to promote vaccination are also anticipated to drive the growth of the Tick Borne Encephalitis Market Industry during the forecast period.
Rising Prevalence of Ticks and Climate Change
The worldwide prevalence of ticks is on the rise due to climate change. As temperature and humidity are the two most important factors concerning this insect, the rise of both significantly affects the threat. The habitat of ticks is increasing due to relevant shifts in weather, which, however, leads to a greater threat of TBE since ticks serve as primary carriers of the virus.
Therefore, the Tick Borne Encephalitis Market Industry is expected to grow due to the increase in the tick population.Critical changes in climate and the resulting shift of ticks’ habitat towards the poles increase the spread of relevant illnesses. Consequently, more vaccines and tick repellents will need to be created to accommodate the increased demand.
Expansion of Travel and Tourism
The following industry driving force could have a significant impact on the dynamics of the Tick Borne Encephalitis Market Industry. Thus, the rising prevalence of TBE along with the growing rates of transmission also fuels the expansion of the TBE market. Due to the rapid expansion of travel and tourism, more people attend regions, where it is endemic, increasing the risks of viral infections.
The current trend is particularly pronounced for the tourists exiting in the open air and walking in the woods or next to waters.As a result, the number of people, seeking the TBE vaccine and other products, designed to minimize the risks of contracting the disease, will continue increasing in the impacted regions.
Tick Borne Encephalitis Market Segment Insights
Tick Borne Encephalitis Market Product Type Insights
The Tick Borne Encephalitis Market is segmented by product type into Tick-Borne Encephalitis (TBE) Vaccines, Tick Repellents, Diagnostic Tests, and Antiviral Drugs. The TBE Vaccines segment is expected to hold the largest market share in 2023, owing to the increasing prevalence of tick-borne encephalitis and the availability of effective vaccines.
The Tick Repellents segment is also expected to witness significant growth, driven by rising awareness about the risks of tick-borne diseases and the increasing use of repellents for personal protection. The Diagnostic Tests segment is expected to grow steadily, supported by the development of new and more accurate diagnostic tools. The Antiviral Drugs segment is expected to have a moderate growth rate, as the market for antiviral drugs for tick-borne encephalitis is relatively small.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Tick Borne Encephalitis Market Distribution Channel Insights
Distribution Channel The Tick Borne Encephalitis Market is segmented by distribution channel into hospitals and clinics, pharmacies and drug stores, online marketplaces, and government agencies. Hospitals and clinics are expected to account for the largest share of the market in 2023, with a market value of 4.2 billion USD. This is due to the increasing number of tick-borne encephalitis cases and the growing demand for effective treatment options.
Pharmacies and drug stores are also expected to experience significant growth in the coming years, with a market value of 2.8 billion USD by 2032. Online marketplaces are expected to grow at the fastest rate, with a CAGR of 7.7%, due to the increasing popularity of online shopping and the convenience of home delivery. Government agencies are also expected to play a significant role in the market, with a market value of 600 million USD by 2032. This is due to the increasing awareness of tick-borne encephalitis and the growing demand for prevention and control measures.
Tick Borne Encephalitis Market End User Insights
The Tick Borne Encephalitis Market segmentation by End User into Travelers, Outdoor Enthusiasts, Healthcare Providers, and Research Institutions offers valuable insights into the diverse market dynamics. Travelers account for a significant portion of the market, with an estimated revenue of USD 5.1 billion in 2024, primarily driven by the rising popularity of adventure tourism and increased travel to endemic regions. Outdoor enthusiasts, including hikers, campers, and hunters, also represent a notable segment, contributing to the market's growth.
Healthcare providers play a crucial role in diagnosing and treating tick-borne encephalitis, with the segment expected to witness steady growth due to the increasing prevalence of the disease. Research institutions are actively involved in developing vaccines and treatments, driving innovation and expanding the market opportunities. This segmentation provides a comprehensive understanding of the target audience, their specific needs, and the growth potential within each segment, enabling stakeholders to tailor their strategies accordingly.
Tick Borne Encephalitis Market TBE Vaccine Type Insights
The TBE Vaccine Type segment is expected to witness significant growth in the coming years, owing to the rising incidence of tick-borne encephalitis (TBE) and the increasing availability of effective vaccines. Inactivated TBE viruses held the largest market share in 2023, and this trend is expected to continue through 2032. The Tick Borne Encephalitis Market revenue for Inactivated TBE Viruses is projected to reach USD 6.2 billion by 2032, exhibiting a CAGR of 7.8%. Live attenuated
TBE viruses are also expected to experience steady growth, with a projected market value of USD 3.4 billion by 2032.Subunit TBE vaccines and DNA-based TBE vaccines are relatively newer technologies, but they are gaining popularity due to their potential for improved efficacy and safety. The Tick Borne Encephalitis Market segmentation data indicates that the market for these vaccines is expected to grow at a CAGR of 8.5% and 9.2%, respectively, during the forecast period.
Tick Borne Encephalitis Market Regional Insights
The Tick Borne Encephalitis Market is segmented into North America, Europe, APAC, South America, and MEA. Among these regions, Europe accounted for the largest market share in 2023, owing to the high prevalence of tick-borne encephalitis in the region. North America is expected to witness significant growth over the forecast period, due to increasing awareness about the disease and the availability of advanced healthcare infrastructure.
APAC is also expected to exhibit promising growth, driven by the rising population and increasing healthcare expenditure in the region. South America and MEA are expected to account for a smaller share of the market but are expected to grow steadily during the forecast period.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Tick Borne Encephalitis Market Key Players And Competitive Insights
Players in the Tick Borne Encephalitis Market are constantly looking for ways to gain a competitive edge over their rivals. Leading Tick Borne Encephalitis Market players are emphasizing developing innovative products and technologies, expanding their geographic reach, and creating strategic partnerships to strengthen their position in the market.
The development of the Tick Borne Encephalitis Market is expected to accelerate in the coming years. The disease has become the focus of increased attention in recent years and continues to be a top priority for both healthcare providers and government policymakers. Advancements in TBE diagnostic technologies and treatment methods are also expected to have a significant impact on market growth.Pfizer is one of the top players on the Tick Borne Encephalitis Market. The vaccine, which is marketed under the brand name Ticovac, is one of the most commonly used vaccines against TBE.
The company’s strong footprint in Europe, one of the continents where TBE is endemic, make the it a top player in the market. In addition to this, the company is also trying to enter new markets such as Asia and the United States. Finally, Pfizer’s investments in research and development have resulted in new and innovative products, such as its next generation of vaccines that will provide longer-lasting protection.Baxter International is another major player in the Tick Borne Encephalitis Market; Encepur, the vaccine sold by the latter, is also commonly used in Europe and other TBE-endemic regions. The company is investing in R to improve their products and develop new treatments for the diseases.
Key Companies in the Tick Borne Encephalitis Market Include
- Merck Co., Inc.
- Emergent BioSolutions Inc.
- Bluebird Bio, Inc.
- Janssen Pharmaceuticals, Inc.
- Gilead Sciences, Inc.
- Arcturus Therapeutics Holdings Inc.
- Moderna, Inc.
- Novavax, Inc.
- Sanofi S.A.
- Bavarian Nordic AS
- Valneva SE
- Seqirus (Australia) Pty Ltd.
- Inovio Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company
- Pfizer Inc.
Tick Borne Encephalitis Market Industry Developments
The global Tick-Borne Encephalitis (TBE) market is expected to witness a steady growth in the coming years, driven by rising awareness of the disease, increasing travel to endemic areas, and technological advancements in vaccine development. In 2023, the market was valued at approximately USD 9.42 billion and is projected to reach USD 17.8 billion by 2032, exhibiting a CAGR of 7.33%.Recent news developments include the approval of new vaccines, such as TicoVac by the European Medicines Agency (EMA) in 2023, expanding the range of available options for TBE prevention. Additionally, ongoing research and clinical trials are exploring new treatment strategies and diagnostic tools for TBE.
Tick Borne Encephalitis Market Segmentation Insights
-
Tick Borne Encephalitis Market Product Type Outlook
- Tick-Borne Encephalitis (TBE) Vaccines
- Tick Repellents
- Diagnostic Tests
- Antiviral Drugs
-
Tick Borne Encephalitis Market Distribution Channel Outlook
- Hospitals and Clinics
- Pharmacies and Drug Stores
- Online Marketplaces
- Government Agencies
-
Tick Borne Encephalitis Market End User Outlook
- Travelers
- Outdoor Enthusiasts
- Healthcare Providers
- Research Institutions
-
Tick Borne Encephalitis Market TBE Vaccine Type Outlook
- Inactivated TBE Viruses
- Live Attenuated TBE Viruses
- Subunit TBE Vaccines
- DNA-Based TBE Vaccines
-
Tick Borne Encephalitis Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
Tick Borne Encephalitis Market Report Scope
| Report Attribute/Metric |
Details |
| Market Size 2022 |
8.78(USD Billion) |
| Market Size 2023 |
9.42(USD Billion) |
| Market Size 2032 |
17.8(USD Billion) |
| Compound Annual Growth Rate (CAGR) |
7.33% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
Merck Co., Inc., Emergent BioSolutions Inc., Bluebird Bio, Inc., Janssen Pharmaceuticals, Inc., Gilead Sciences, Inc., Arcturus Therapeutics Holdings Inc., Moderna, Inc., Novavax, Inc., Sanofi S.A., Bavarian Nordic AS, Valneva SE, Seqirus (Australia) Pty Ltd., Inovio Pharmaceuticals, Inc., Takeda Pharmaceutical Company, Pfizer Inc. |
| Segments Covered |
Product Type, Distribution Channel, End User, TBE Vaccine Type, Regional |
| Key Market Opportunities |
Growing geriatric population, rising incidence of tick bites, increasing awareness about TBE, expanding healthcare infrastructure in emerging markets and advancements in vaccine development |
| Key Market Dynamics |
Increased disease incidence Growing awareness of preventive measures Technological advancements in diagnostics and therapeutics Government initiatives for surveillance and control Rising demand for effective and safe vaccines |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Tick Borne Encephalitis Market is projected to have an overall valuation of 9.42 USD Billion in 2023.
The Tick Borne Encephalitis Market is projected to have an overall valuation of 17.8 USD Billion by 2032
The Tick Borne Encephalitis Market is projected to grow at a CAGR of 7.33% from 2024 to 2032.
Europe is expected to hold the largest market share in the Tick Borne Encephalitis Market in 2032.
The diagnostic segment is expected to hold the largest market share in the Tick Borne Encephalitis Market in 2032.
Some of the key competitors in the Tick Borne Encephalitis Market include Pfizer, Merck, and Sanofi.
Some of the key trends driving the growth of the Tick Borne Encephalitis Market include the increasing incidence of tick-borne diseases, the rising awareness of tick-borne encephalitis, and the development of new and effective vaccines and treatments.
Some of the challenges facing the Tick Borne Encephalitis Market include the lack of access to vaccines and treatments in some regions, the high cost of vaccines and treatments, and the emergence of new strains of tick-borne encephalitis virus.
The COVID-19 pandemic is expected to have a negative impact on the Tick Borne Encephalitis Market in the short term, due to the disruption of healthcare services and the diversion of resources to the COVID-19 response.
Some of the opportunities for growth in the Tick Borne Encephalitis Market include the development of new and more effective vaccines and treatments, the expansion of access to vaccines and treatments in underserved regions, and the development of new diagnostic tools.
